Massachusetts Financial Services
ABMD

Massachusetts Financial Services’s Abiomed Inc ABMD Stock Holding History

Massachusetts Financial Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-98,936
Closed -$28.3M – 874
2019
Q1 		$28.3M Sell
98,936
-90,862
-48% -$30.2M 0.01% 477
2018
Q4 		$61.7M Buy
189,798
+12,545
+7% +$4.36M 0.03% 353
2018
Q3 		$79.7M Buy
177,253
+34,284
+24% +$13.5M 0.03% 333
2018
Q2 		$58.5M Buy
142,969
+99,780
+231% +$36.1M 0.03% 374
2018
Q1 		$12.6M Buy
+43,189
New +$10.9M 0.01% 582

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Massachusetts Financial Services's ABMD Position: Q2 2019 in Review

Massachusetts Financial Services sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 98,936 shares — an estimated $28.3M sold.

Massachusetts Financial Services first reported a position in ABMD in Q1 2018 and held it in 5 quarters. The position peaked at $79.7M in Q3 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Massachusetts Financial Services reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Massachusetts Financial Services sold 98,936 Abiomed Inc shares in Q2 2019, an estimated $28.3M.
  • Massachusetts Financial Services first reported a position in Abiomed Inc in Q1 2018 and held it in 5 quarters.
  • Massachusetts Financial Services's Abiomed Inc position peaked at $79.7M in Q3 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Massachusetts Financial Services's 13F filing for Q2 2019, filed 14 Aug 2019.